<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02727270</url>
  </required_header>
  <id_info>
    <org_study_id>15183</org_study_id>
    <secondary_id>3794</secondary_id>
    <secondary_id>5338</secondary_id>
    <nct_id>NCT02727270</nct_id>
  </id_info>
  <brief_title>Measuring Cortisol Levels in Persons With Parkinson's (PD)</brief_title>
  <acronym>CORT-PD</acronym>
  <official_title>Measuring Cortisol Levels in Persons With Parkinson's (PD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Portland VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Clinical and Translational Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the cortisol awakening response with persons with
      PD and moderate levels of stress as compared to controls and persons with PD and low levels
      of stress. These data are desired so experience can be gained with measuring stress levels
      subjectively and objectively in persons with PD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Telephone consent will be obtained. Participants will collect saliva at twelve time points -
      (four times a day for three days prior to their in-person visit). Participants will then have
      a half-hour in-person visit at the VA to assess stress, mood, quality of life, and
      Parkinson's.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Awakening Salivary Cortisol level (ug/dL) Response</measure>
    <time_frame>Collected upon awakening and 30 minutes after awakening</time_frame>
    <description>Salivary Cortisol level (ug/dL) Response is the change in cortisol between awakening and 30 minutes after awakening.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Parkinson's - High Stress</arm_group_label>
    <description>Parkinson's disease patients with self-reported high strain/stress.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parkinson's - Low Stress</arm_group_label>
    <description>Parkinson's disease patients with self-reported low strain/stress.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Healthy controls (no neurological disease).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Intervention - Observational Study</intervention_name>
    <description>No Intervention - Observational Study</description>
    <arm_group_label>Parkinson's - High Stress</arm_group_label>
    <arm_group_label>Parkinson's - Low Stress</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators plan to enroll three groups: (1) person with PD and moderate levels of
        self-reported stress, (2) persons with PD and low levels of self-reported stress, and (3)
        controls
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Group (1) Inclusion:

          -  PD as confirmed by NINDS criteria

          -  PD confirmed by a movement disorders specialist

          -  a Perceived Stress Scale (PSS) score higher than or equal to 13.

        Group (2) Inclusion:

          -  PD as confirmed by NINDS criteria

          -  PD confirmed by a movement disorders specialist

          -  PSS score lower than 13.

        Group (3) Inclusion:

          -  No significant neurological disorder

          -  PSS score of less than 13.

        Exclusion Criteria:

          -  The use of medications known to effect cortisol levels (estrogen, synthetic
             glucocorticoids, androgens, phenytoin, spironolactone, prednisone, prednisolone, and
             hydrocortisone).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amie L Hiller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brenna M Lobb, MS, MPH</last_name>
    <phone>503.220.8262</phone>
    <phone_ext>51871</phone_ext>
    <email>lobbb@ohsu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Susan M O'Connor, RN</last_name>
    <phone>503.220.8262</phone>
    <phone_ext>51091</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oregon Health &amp; Science Universtiy</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenna Lobb, MS MPH</last_name>
      <phone>503-220-8262</phone>
      <phone_ext>51871</phone_ext>
      <email>lobbb@ohsu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VA Portland Health Care System</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenna Lobb, MS MPH</last_name>
      <phone>503-220-8262</phone>
      <phone_ext>51871</phone_ext>
      <email>lobbb@ohsu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ceravolo R, Frosini D, Poletti M, Kiferle L, Pagni C, Mazzucchi S, Volterrani D, Bonuccelli U. Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction. Eur J Neurol. 2013 Mar;20(3):480-5. doi: 10.1111/j.1468-1331.2012.03878.x. Epub 2012 Oct 18.</citation>
    <PMID>23078376</PMID>
  </reference>
  <reference>
    <citation>Hartmann A, Veldhuis JD, Deuschle M, Standhardt H, Heuser I. Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol Aging. 1997 May-Jun;18(3):285-9.</citation>
    <PMID>9263193</PMID>
  </reference>
  <reference>
    <citation>Marsden CD, Owen DA. Mechanisms underlying emotional variation in parkinsonian tremor. Neurology. 1967 Jul;17(7):711-5.</citation>
    <PMID>6067490</PMID>
  </reference>
  <reference>
    <citation>Matousek RH, Dobkin PL, Pruessner J. Cortisol as a marker for improvement in mindfulness-based stress reduction. Complement Ther Clin Pract. 2010 Feb;16(1):13-9. doi: 10.1016/j.ctcp.2009.06.004. Epub 2009 Jul 4. Review.</citation>
    <PMID>20129404</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2016</study_first_submitted>
  <study_first_submitted_qc>March 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2016</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Amie Hiller, MD</investigator_full_name>
    <investigator_title>Neurologist</investigator_title>
  </responsible_party>
  <keyword>Movement disorders</keyword>
  <keyword>Metabolic Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

